Cypherpunk Technologies (CYPH) vs Vanda Pharmaceuticals (VNDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cypherpunk Technologies (CYPH) has outperformed Vanda Pharmaceuticals (VNDA) over the past year, gaining 274.7% versus a loss of 17.0%. Over five years, VNDA leads with a -75.4% price change compared with -91.1% for CYPH. Cypherpunk Technologies is the larger company by market cap ($302.8 million vs $273.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CYPH | VNDA |
|---|---|---|
| Share price | $2.81 | $4.53 |
| Market cap | $302.82M | $273.90M |
| 1-day change | -7.87% | -0.66% |
| YTD return | +142.24% | -48.64% |
| 1-year return | +274.67% | -17.03% |
| 5-year return | -91.08% | -75.39% |
| P/E ratio (TTM) | 4.46 | — |
| Forward P/E | — | 22.65 |
| EPS (TTM) | $0.63 | $-4.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $9.94 |
| 52-week low | $0.393 | $4.27 |
| Distance from 52-week high | -32.94% | -54.43% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +74.38% | +159.38% |
| Average volume | 10.07M | 974.13K |
| Shares outstanding | 107.76M | 60.46M |
| Employees | 6 | 533 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CYPH has outperformed VNDA by 291.7 percentage points over the past year.
- The two companies sit in different sectors: Cypherpunk Technologies in Health Care and Vanda Pharmaceuticals in Healthcare.
About Cypherpunk Technologies
CYPH stock →Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Vanda Pharmaceuticals
VNDA stock →Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion.
Healthcare · Biotechnology · 533 employees
CYPH vs VNDA FAQ
Which is bigger, Cypherpunk Technologies or Vanda Pharmaceuticals?
Cypherpunk Technologies (CYPH) is larger, with a market capitalization of $302.82M compared with $273.90M for Vanda Pharmaceuticals (VNDA).
Which stock has performed better over the past year, CYPH or VNDA?
CYPH returned +274.67% over the past 12 months, compared with -17.03% for VNDA (price return, excluding dividends). Past performance does not predict future results.
Are Cypherpunk Technologies and Vanda Pharmaceuticals in the same industry?
No. Cypherpunk Technologies is in the Health Care sector, while Vanda Pharmaceuticals is in Healthcare.